yahoo_financeOriginal article
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
Positive
AI Analysis
Summary
DelveInsight market analysis forecasts strong uptake in the inflammatory bowel disease market from 2026-2036, driven by development of next-generation therapies targeting IL-23, TL1A, and S1P pathways. This is a market research report with no specific clinical or regulatory catalyst.
Importance:2/10
Sentiment:
0.30
inflammatory bowel diseasemarket analysisIL-23 pathwayTL1A pathwayS1P pathwaynext-generation therapiesforecast 2026-2036
Related Companies
Read the original article
Published by yahoo_finance on July 30, 2026 2:31 PM